Abstract
Introduction:
Improving fat absorption remains a challenge in cystic fibrosis (CF). Antibiotics (AB) treatment has been shown to improve body weight in CF mice. The mechanism may include improvement in fat absorption. We aimed to determine the effect of AB on fat absorption in two CF mouse models.
Results:
AB did not improve total fat absorption. Interestingly, AB accelerated the absorption of isotope-labeled fats, in both Δ/Δ and WT mice. The changes observed were not related to the solubilization capacity of bile or to changes in the bacteria in the small intestine. AB reduced the fecal excretion of cholate by ~50% (P < 0.05) in both CF mouse models, indicating improved intestinal bile salt absorption.
Discussion:
In conclusion, AB treatment does not improve total fat absorption in CF mice but does decrease fecal loss of bile salts and accelerate long-chain fatty acid (LCFA) absorption.
Methods:
For 3 weeks, we administered oral AB (ciprofloxacin/metronidazole) or control treatment to homozygous ΔF508 (Δ/Δ), cystic fibrosis transmembrane conductance regulator (CFTR) knockout (−/−), and wild-type (WT) mice and quantified fat absorption using a 72-h fat balance test. In Δ/Δ mice, we assessed fat absorption kinetics by administering tri-1-13C-palmitin and 1-13C-stearate intragastrically and determining the appearance of stable isotope-labeled fats in plasma. We quantified biliary and fecal bile salts (gas chromatography) and small intestinal bacteria (quantitative-PCR).
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Sinaasappel M, Stern M, Littlewood J,et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002;1:51–75.
Borowitz D, Durie PR, Clarke LL, et al. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr 2005;41: 273–85.
Saiman L, Anstead M, Mayer-Hamblett N,et al.; AZ0004 Azithromycin Study Group. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2010;303:1707–15.
Saiman L, Marshall BC, Mayer-Hamblett N,et al.; Macrolide Study Group. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003;290:1749–56.
Norkina O, Burnett TG, De Lisle RC . Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 2004;72:6040–9.
Rana SV, Bhardwaj SB . Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008;43:1030–7.
Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, Verkade HJ . Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am J Physiol Gastrointest Liver Physiol 2005;288:G646–53.
Martin FP, Dumas ME, Wang Y,et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol 2007;3:112.
Savage DC, Dubos R . Alterations in the mouse cecum and its flora produced by antibacterial drugs. J Exp Med 1968;128:97–110.
Strandvik B, Einarsson K, Lindblad A, Angelin B . Bile acid kinetics and biliary lipid composition in cystic fibrosis. J Hepatol 1996;25:43–8.
O’Brien S, Mulcahy H, Fenlon H,et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137–41.
De Lisle RC, Roach EA, Norkina O . Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. J Pediatr Gastroenterol Nutr 2006;42:46–52.
De Lisle RC . Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2007;293:G104–11.
Norkina O, Kaur S, Ziemer D, De Lisle RC . Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2004;286:G1032–41.
Durie PR, Newth CJ, Forstner GG, Gall DG . Malabsorption of medium-chain triglycerides in infants with cystic fibrosis: correction with pancreatic enzyme supplement. J Pediatr 1980;96:862–4.
de Somer P, Eyssen H, Evrard E. The influence of antibiotics on fecal fat in chicks. In: Frazer AC, ed. Biochemical Problems of Lipids. Amsterdam: Elsevier, 1963: 84–90.
Gonzalez J, Fernandez C, Marino E, Morales A, Jimenez R . Biliary excretion and choleretic effect of cefmetazole in rats. Antimicrob Agents Chemother 1989;33:1970–4.
Verkade HJ, van Asselt WA, Vonk RJ,et al. Fat absorption in premature infants: the effect of lard and antibiotics. Eur J Pediatr 1989;149:126–9.
Le Dafniet M, Pessayre D, Le Quernec L, Erlinger S . Effects of troleandomycin administration on cholesterol 7 alpha-hydroxylase activity and bile secretion in rats. J Pharmacol Exp Ther 1981;219:558–62.
Toda T, Ohi K, Kudo T,et al. Ciprofloxacin suppresses Cyp3a in mouse liver by reducing lithocholic acid-producing intestinal flora. Drug Metab Pharmacokinet 2009;24:201–8.
Eklund A, Norman A, Strandvik B . Excretion of bile acids in healthy children and children with cystic fibrosis. Scand J Clin Lab Invest 1980;40:595–608.
Muskiet FA, van Doormaal JJ, Martini IA, Wolthers BG, van der Slik W . Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J Chromatogr 1983;278:231–44.
Setchell KD, Worthington J . A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges. Clin Chim Acta 1982;125:135–44.
Heuman DM . Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989;30:719–30.
Millar JS, Cromley DA, McCoy MG, Rader DJ, Billheimer JT . Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J Lipid Res 2005;46:2023–8.
Barman M, Unold D, Shifley K,et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 2008;76:907–15.
Salzman NH, de Jong H, Paterson Y, Harmsen HJ, Welling GW, Bos NA . Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002;148(Pt 11): 3651–60.
van der Sluis M, Melis MH, Jonckheere N,et al. The murine Muc2 mucin gene is transcriptionally regulated by the zinc-finger GATA-4 transcription factor in intestinal cells. Biochem Biophys Res Commun 2004;325:952–60.
Acknowledgements
We thank H. Jorna, T. Boer, I. Martini, R. Boverhof, and S.C. Beijer-Liefers for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wouthuyzen-Bakker, M., Bijvelds, M., de Jonge, H. et al. Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. Pediatr Res 71, 4–12 (2012). https://doi.org/10.1038/pr.2011.4
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pr.2011.4
This article is cited by
-
Prevalence of Fecal Incontinence in Adults with Cystic Fibrosis
Digestive Diseases and Sciences (2018)
-
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
Scientific Reports (2017)
